Levy Raphi 4

What Happened

• Levy Raphi, Chief Financial Officer of Alpha Tau Medical Ltd. (DRTS), exercised 17,873 shares by conversion of a derivative (code M) at $2.98 per share (cost $53,262) on 2026-07-02 and then sold the same 17,873 shares in an open-market transaction (code S) at $13.00 per share, generating $232,397 in gross sale proceeds. Net proceeds before taxes/fees approximate $179,135 (sale proceeds minus exercise cost).

Key Details

• Transaction date(s): 2026-07-02.
• Exercise: 17,873 shares at $2.98 = $53,262 (code M).
• Sale: 17,873 shares at $13.00 = $232,397 (code S).
• Shares owned after the transaction: not stated in the data provided (see the Form 4 for the precise post-transaction holdings).
• Footnotes / plans: no 10b5-1 plan, tax-withholding, or other footnotes were provided in the summary data supplied here — check the full filing for any notes.
• Filing date: Form 4 filed 2026-07-06. The provided data does not indicate a late-filing flag.

Context

• This sequence (exercise followed by immediate sale) is commonly a cashless exercise: the insider exercises options and sells the shares immediately, often to cover exercise costs and tax withholding. The trade resulted in no net increase in shares held by the insider according to the transactions reported. Transaction codes: M = option exercise/conversion; S = sale.